Danielle Antalffy
Stock Analyst at UBS
(3.51)
# 888
Out of 4,983 analysts
179
Total ratings
48.57%
Success rate
5.63%
Average return
Main Sectors:
Stocks Rated by Danielle Antalffy
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MDT Medtronic | Maintains: Neutral | $94 → $95 | $94.19 | +0.86% | 11 | Aug 20, 2025 | |
| TMCI Treace Medical Concepts | Maintains: Neutral | $8.6 → $6.5 | $7.08 | -8.19% | 7 | Aug 8, 2025 | |
| RXST RxSight | Maintains: Neutral | $16 → $8 | $9.08 | -11.89% | 4 | Aug 8, 2025 | |
| ENOV Enovis | Maintains: Buy | $65 → $57 | $33.32 | +71.07% | 2 | Aug 8, 2025 | |
| ZBH Zimmer Biomet Holdings | Maintains: Sell | $91 → $96 | $99.12 | -3.15% | 5 | Aug 8, 2025 | |
| TNDM Tandem Diabetes Care | Maintains: Neutral | $20 → $17 | $12.43 | +36.77% | 15 | Aug 7, 2025 | |
| INSP Inspire Medical Systems | Maintains: Buy | $270 → $230 | $80.80 | +184.65% | 6 | Aug 5, 2025 | |
| BAX Baxter International | Maintains: Neutral | $35 → $24 | $23.87 | +0.54% | 6 | Aug 4, 2025 | |
| GKOS Glaukos | Maintains: Buy | $125 → $134 | $82.35 | +62.72% | 2 | Jul 31, 2025 | |
| DXCM DexCom | Maintains: Buy | $105 → $106 | $76.55 | +38.47% | 9 | Jul 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $130 → $135 | $98.98 | +36.39% | 13 | Jul 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $547 → $585 | $434.50 | +34.64% | 2 | Jul 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $180 → $190 | $176.46 | +7.67% | 5 | Jul 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $60 → $58 | $35.96 | +61.29% | 13 | Apr 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $19 → $16 | $14.96 | +8.62% | 4 | Apr 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5.5 → $5 | $3.49 | +43.27% | 2 | Jan 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $146 → $148 | $132.76 | +11.48% | 12 | Jan 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $366 → $370 | $376.62 | -1.76% | 6 | Oct 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $90 → $75 | $75.09 | -0.12% | 12 | Sep 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $2.25 | $1.63 | +38.04% | 1 | Mar 29, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $300 → $280 | $332.13 | -15.70% | 12 | May 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $975 → $825 | $13.85 | +5,856.68% | 2 | May 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $12 → $14 | $16.73 | -16.32% | 1 | May 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $75 → $100 | $51.98 | +92.38% | 2 | May 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $15 → $12 | $9.80 | +22.45% | 3 | Mar 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $25 → $30 | $39.57 | -24.18% | 3 | Mar 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $40 → $45 | $33.23 | +35.42% | 4 | Feb 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $270 → $275 | $186.21 | +47.68% | 1 | Feb 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $26 → $20 | $4.86 | +311.52% | 3 | Nov 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $72 → $42 | $8.50 | +394.12% | 7 | Nov 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | $3 | $0.45 | +568.00% | 3 | Apr 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $15 | $0.91 | +1,549.98% | 1 | Sep 1, 2020 |
Medtronic
Aug 20, 2025
Maintains: Neutral
Price Target: $94 → $95
Current: $94.19
Upside: +0.86%
Treace Medical Concepts
Aug 8, 2025
Maintains: Neutral
Price Target: $8.6 → $6.5
Current: $7.08
Upside: -8.19%
RxSight
Aug 8, 2025
Maintains: Neutral
Price Target: $16 → $8
Current: $9.08
Upside: -11.89%
Enovis
Aug 8, 2025
Maintains: Buy
Price Target: $65 → $57
Current: $33.32
Upside: +71.07%
Zimmer Biomet Holdings
Aug 8, 2025
Maintains: Sell
Price Target: $91 → $96
Current: $99.12
Upside: -3.15%
Tandem Diabetes Care
Aug 7, 2025
Maintains: Neutral
Price Target: $20 → $17
Current: $12.43
Upside: +36.77%
Inspire Medical Systems
Aug 5, 2025
Maintains: Buy
Price Target: $270 → $230
Current: $80.80
Upside: +184.65%
Baxter International
Aug 4, 2025
Maintains: Neutral
Price Target: $35 → $24
Current: $23.87
Upside: +0.54%
Glaukos
Jul 31, 2025
Maintains: Buy
Price Target: $125 → $134
Current: $82.35
Upside: +62.72%
DexCom
Jul 31, 2025
Maintains: Buy
Price Target: $105 → $106
Current: $76.55
Upside: +38.47%
Jul 24, 2025
Maintains: Buy
Price Target: $130 → $135
Current: $98.98
Upside: +36.39%
Jul 23, 2025
Maintains: Neutral
Price Target: $547 → $585
Current: $434.50
Upside: +34.64%
Jul 17, 2025
Maintains: Buy
Price Target: $180 → $190
Current: $176.46
Upside: +7.67%
Apr 30, 2025
Maintains: Buy
Price Target: $60 → $58
Current: $35.96
Upside: +61.29%
Apr 29, 2025
Maintains: Neutral
Price Target: $19 → $16
Current: $14.96
Upside: +8.62%
Jan 27, 2025
Maintains: Buy
Price Target: $5.5 → $5
Current: $3.49
Upside: +43.27%
Jan 23, 2025
Maintains: Buy
Price Target: $146 → $148
Current: $132.76
Upside: +11.48%
Oct 30, 2024
Maintains: Neutral
Price Target: $366 → $370
Current: $376.62
Upside: -1.76%
Sep 10, 2024
Maintains: Neutral
Price Target: $90 → $75
Current: $75.09
Upside: -0.12%
Mar 29, 2023
Initiates: Neutral
Price Target: $2.25
Current: $1.63
Upside: +38.04%
May 6, 2022
Maintains: Outperform
Price Target: $300 → $280
Current: $332.13
Upside: -15.70%
May 5, 2022
Maintains: Outperform
Price Target: $975 → $825
Current: $13.85
Upside: +5,856.68%
May 5, 2022
Maintains: Outperform
Price Target: $12 → $14
Current: $16.73
Upside: -16.32%
May 2, 2022
Maintains: Outperform
Price Target: $75 → $100
Current: $51.98
Upside: +92.38%
Mar 11, 2022
Maintains: Outperform
Price Target: $15 → $12
Current: $9.80
Upside: +22.45%
Mar 9, 2022
Maintains: Outperform
Price Target: $25 → $30
Current: $39.57
Upside: -24.18%
Feb 25, 2022
Maintains: Outperform
Price Target: $40 → $45
Current: $33.23
Upside: +35.42%
Feb 4, 2022
Maintains: Market Perform
Price Target: $270 → $275
Current: $186.21
Upside: +47.68%
Nov 10, 2021
Maintains: Outperform
Price Target: $26 → $20
Current: $4.86
Upside: +311.52%
Nov 5, 2021
Maintains: Market Perform
Price Target: $72 → $42
Current: $8.50
Upside: +394.12%
Apr 1, 2021
Downgrades: Market Perform
Price Target: $3
Current: $0.45
Upside: +568.00%
Sep 1, 2020
Initiates: Outperform
Price Target: $15
Current: $0.91
Upside: +1,549.98%